Αποτελέσματα Αναζήτησης
6 Οκτ 2024 · Diagnosis is made through blood tests measuring iron levels and genetic testing. Treatment of hemochromatosis primarily involves regular phlebotomy to remove excess iron from the body, and early detection can prevent severe organ damage. Objectives:
17 Ιουλ 2023 · Apply best practices when utilizing laboratory and other diagnostic testing to monitor disease progression in patients with hereditary hemochromatosis. Develop and implement interprofessional team processes to improve outcomes and prevent complications in patients with hereditary hemochromatosis.
19 Μαΐ 2022 · Here we present recommendations for unambiguous HC classification developed by a working group of the International Society for the Study of Iron in Biology and Medicine (BIOIRON Society), including both clinicians and basic scientists during a meeting in Heidelberg, Germany.
5 Απρ 2018 · Haemochromatosis is defined as systemic iron overload of genetic origin, caused by a reduction in the concentration of the iron regulatory hormone hepcidin, or a reduction in hepcidin-ferroportin binding. Hepcidin regulates the activity of ferroportin, which is the only identified cellular iron exporter.
8 Νοε 2022 · This JAMA Insights Clinical Review discusses the diagnosis and management of hereditary hemochromatosis, including clinical and laboratory characteristics, gene testing and interpretation, and the role of imaging and liver biopsy.
5 Απρ 2018 · Diagnosis is noninvasive and includes clinical examination, assessment of plasma iron parameters, imaging and genetic testing. The mainstay therapy is phlebotomy, although iron chelation can be used in some patients.
PMID: 27170390. DOI: 10.1159/000444549. Abstract. Hemochromatosis is a common cause of chronic liver disease and HFE genotyping allows decisive and non-invasive diagnosis.
